Lantheus Holdings Inc
NASDAQ:LNTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
US |
|
C.Uyemura & Co Ltd
OTC:CUYRF
|
JP |
Intrinsic Value
The intrinsic value of Lantheus Holdings Inc (LNTH) under the Base Case is 100.806 USD per share.
Compared with the current market price of 101.095 USD, the stock appears
Fairly Valued .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Lantheus Does
Lantheus Holdings makes diagnostic products that help doctors see disease inside the body, especially in cancer and heart imaging. Its main products are imaging agents used with PET, SPECT, ultrasound, and other scans, including the prostate cancer tracer PYLARIFY and the ultrasound contrast agent DEFINITY. These products do not treat patients directly; they help hospitals and imaging centers find and track disease more accurately.
- Headquarters
- United States of America US
- Employees
- 1 193
- IPO date
- Jun 25, 2015
Lantheus Holdings has a wide economic moat
Lantheus Holdings Inc possesses a wide economic moat, providing strong and durable advantages that protect its market position and profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Lantheus Holdings Inc
Earnings Waterfall
Lantheus Holdings Inc
The intrinsic value for Lantheus Holdings Inc (LNTH) under the Base Case is 100.806 USD.
Compared with the current market price of 101.095 USD, the stock appears Fairly Valued .
